📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
151,859
All-time analysed
43,535
Positive
6,743
Negative
92,744
Neutral
8,769
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
24 announcements match the current filters (relevance ≥ 5).
Virinchi Promoter to Invest in Subsidiary via 52.22 Lakh Warrants at Rs 15 Each
Virinchi Limited's board has approved a proposal for its promoter, Mr. Viswanath Kompella, to invest in its material subsidiary, Virinchi Health Care Private Limited. The investment involves the issuance of 52,22,000 convertible equity warrants at a price of Rs. 15 per warrant, based on an enterprise valuation of Rs. 312.08 crore for the subsidiary. This transaction will result in the promoter holding up to 49% of the subsidiary's post-issue equity capital. The capital infusion is intended to improve liquidity and strengthen the subsidiary's balance sheet for long-term growth.
Key Highlights
Promoter Mr. Viswanath Kompella to acquire up to 49% stake in material subsidiary Virinchi Health Care
Issuance of 52,22,000 convertible equity warrants at Rs. 15 per warrant (FV Rs. 10 + Premium Rs. 5)
Subsidiary enterprise valuation pegged at Rs. 312.08 crore by an independent valuer
Warrants have a conversion tenure of 36 months from the date of allotment
Investment aimed at improving liquidity and strengthening the subsidiary's balance sheet
👀 What to Watch
Investors should view the promoter's direct capital infusion as a sign of confidence in the healthcare vertical, though they should monitor the impact of equity dilution in the subsidiary on consolidated earnings.
Virinchi Allots 74 Lakh Convertible Warrants to Promoter Group at Rs 28 Per Share
Virinchi Limited has approved the allotment of 74,00,000 convertible equity warrants to Vivo Bio Tech Limited, a promoter group entity. The warrants are issued at Rs 28 each, with the company receiving 25% (Rs 5.18 crore) upfront and the remaining 75% due upon conversion within 18 months. This move is expected to increase the promoter group's stake from 37.51% to 41.71% upon full conversion of this tranche. The funds will likely support the company's capital requirements or growth initiatives.
Key Highlights
74,00,000 warrants allotted to promoter group entity Vivo Bio Tech Limited at Rs 28 per warrant.
Immediate cash inflow of Rs 5.18 crore representing 25% of the total issue price.
Promoter group shareholding projected to rise to 41.71% from 37.51% after conversion.
Warrants are convertible into equity shares on a 1:1 basis within a maximum period of 18 months.
👀 What to Watch
The promoter's decision to increase their stake at a fixed price indicates long-term commitment and confidence. Investors should monitor the company's upcoming quarterly results to see if the capital infusion translates into improved operational performance.
Virinchi Ltd Allots 86 Lakh Convertible Warrants to Promoter Group at Rs 28 Per Share
Virinchi Limited has approved the allotment of 86,00,000 convertible equity warrants to Vivo Bio Tech Limited, a promoter group entity. The warrants are issued at a price of Rs. 28 each, with the company receiving 25% (Rs. 6.02 crore) of the total consideration upfront. The remaining 75% is payable within 18 months upon conversion into equity shares. This move is expected to increase the promoter group's stake from 37.51% to 42.34% on a fully diluted basis, indicating strong internal confidence.
Key Highlights
Allotment of 86,00,000 convertible warrants to promoter group entity Vivo Bio Tech Limited
Issue price set at Rs. 28 per warrant, including a premium of Rs. 18
Immediate capital infusion of Rs. 6.02 crore representing 25% of the total subscription amount
Promoter holding projected to increase from 37.51% to 42.34% upon full conversion
Warrants are convertible into equity shares within a maximum period of 18 months
👀 What to Watch
Investors should note the promoter group's increased stake as a sign of long-term commitment and confidence in the company's valuation. Monitor the conversion of the remaining warrants and the deployment of the raised capital into growth initiatives.
Virinchi Ltd Allots 40 Lakh Convertible Warrants at Rs 28 Per Unit
Virinchi Limited has approved the allotment of 40,00,000 convertible equity warrants to IT Peer Technologies LLC on a preferential basis. The warrants are issued at a price of Rs. 28 per unit, with the company receiving 25% (Rs. 2.80 crore) of the total consideration upfront. The remaining 75% (Rs. 21 per warrant) is payable within 18 months for conversion into equity shares. This allotment is part of a larger shareholder-approved plan to issue up to 2 crore warrants.
Key Highlights
Allotment of 40,00,000 convertible warrants at an issue price of Rs. 28 (Face Value Rs. 10 + Premium Rs. 18)
Immediate capital infusion of Rs. 2.80 crore representing 25% of the total subscription amount
Warrants are convertible into equity shares on a 1:1 basis within a maximum period of 18 months
Allottee IT Peer Technologies LLC belongs to the Public category, increasing public shareholding post-conversion
Total equity base to expand from 10.26 crore to 10.66 crore shares upon full conversion of these warrants
👀 What to Watch
Investors should track the utilization of the raised capital for growth initiatives and note the potential equity dilution of approximately 3.7% from this specific allotment. The issue price of Rs. 28 provides a floor valuation reference for the stock over the medium term.
